Development of a statistical approach to classifying treatment response in individual children with ADHD

Human Psychopharmacology

Volumn 19, Issue 7, 2004, Pages 445-456

  Mollica, Catherine M ^a,e   Maruff, Paul ^a,b   Vance, Alasdair ^c,d  

^a LA TROBE UNIVERSITY   (Australia)

^b CogState Ltd ^*  (Australia)

^c ALFRED HOSPITAL   (Australia)

^d ROYAL CHILDREN'S HOSPITAL   (Australia)

^e NONE   (Australia)

Author keywords

ADHD; Cognitive function; Dexamphetamine; Single case analysis

Indexed keywords

CENTRAL STIMULANT AGENT; DEXAMPHETAMINE;

AGE; ARTICLE; ATTENTION DEFICIT DISORDER; CHILD BEHAVIOR; CLASSIFICATION; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; DATA ANALYSIS; DOSE RESPONSE; DRUG MEGADOSE; DRUG RESPONSE; ERROR; EVIDENCE BASED MEDICINE; FEMALE; FUNCTIONAL ASSESSMENT; GENDER; HUMAN; INTELLIGENCE QUOTIENT; LOW DRUG DOSE; MALE; PRIORITY JOURNAL; SCHOOL CHILD; SENSITIVITY AND SPECIFICITY; STATISTICAL ANALYSIS; TREATMENT OUTCOME;

ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CHILD; CHILD BEHAVIOR; COGNITION; DEXTROAMPHETAMINE; FEMALE; HUMANS; MALE;

EID: 5744224678     PISSN: 08856222     EISSN: None     Source Type: Journal    
DOI: 10.1002/hup.624     Document Type: Article

References (52)

1. Achenbach TM (ed.). 1991. Manual for the Child Behaviour Checklist/4-18 and 1991 Profile. University of Vermont Department of Psychiatry: Burlington VT, 1991.
2. Aman MG, Turbott SH. 1991. Prediction of clinical response in children taking methylphenidate. J Autism Dev Disord 21: 211-228.
3. American Psychiatric Association (ed.). 1994. Diagnostic and Statistical Manual of Mental Disorders, 4th edn. APA: Washington DC, 1994.
4. Barnett R, Maruff P, Vance A, McStephen M, Costin J, Luk ESL. 2004a. An investigation of non-verbal memory impairment in ADHD: the effects of psychostimulant medication encoding and strategy. Dev Neuropsychol in press.
5. Barnett R, Maruff P, Vance A, Wood K, Costin J, Luk E. 2004b. Executive and cognitive dysfunction in ADHD. J Clin Child Psychol in press.
6. Bedard AC, Ickowicz A, Logan GD, Hogg-Johnson S, Schachar R, Tannock R. 2003. Selective inhibition in children with Attention-Deficit Hyperactivity Disorder off and on stimulant medication. J Abnorm Child Psychol 31: 315-327.
7. Bergman A, Winters L, Cornblatt B. 1991. Methylphenidate: effects on sustained attention. In Ritalin: Theory and Patient Management, Greenhill L, Osman B (eds). Mary Ann Liebert: New York, 223-231.
8. Bland JM, Altman DG. 1996. Statistical notes: measurement error. Br Med J 313: 744.
9. Buitelaar JK, van der Gaag RJ, Swaab-Barneveld H, Kuiper M. 1995. Prediction of clinical response to methylphenidate in children with Attention-Deficit Hyperactivity Disorder. J Am Acad Child Adolesc Psychiatry 34: 1025-1032.
10. Cairney S, Maruff P, Vance A, Barnett R, Luk E, Currie J. 2001. Contextual abnormalities of saccadic inhibition in children with attention deficit hyperactivity disorder. Exp Brain Res 141: 507-518.
11. Castellanos FX, Tannock R. 2002. Neuroscience of Attention-Deficit/Hyperactivity Disorder: the search for endophenotypes. Nat Rev Neurosci 3: 617-628.
12. Collie A, Darby DG, Falleti MG, Silbert BS, Maruff P. 2002. Determining the extent of cognitive change after coronary surgery: a review of statistical procedures. Ann Thorac Surg 73: 2005-2011.
13. Collie A, Maruff P, Makdissi M, McCrory P, McStephen M, Darby D. 2003a. CogSport: reliability and correlation with conventional cognitive tests used in post-concussion medical evaluations. Clin J Sport Med 13: 28-32.
14. Collie A, Maruff P, McStephen M, Darby DG. 2003b. The effects of practice on the cognitive test performance of neurologically normal individuals assessed at brief test-retest intervals. J Int Neuropsychol Soc 9: 419-428.
15. Conners CK. 1985. Parent Symptom Questionnaire. Psychopharmacology 21: 816-822.
16. Conners CK. 2002. Forty years of methylphenidate treatment in Attention-Deficit/Hyperactivity Disorder. J Attent Disord 5: S17-S30.
17. Conners CK, Epstein JN, March JS, et al. 2001. Multimodal treatment of ADHD in the MAT: an alternative outcome analysis. J Am Acad Child Adolesc Psychiatry 40: 159-167.
18. Denney CB, Rapport MD. 1999. Predicting methylphenidate response in children with ADHD: theoretical empirical and conceptual models. J Am Acad Child Adolesc Psychiatry 38: 393-401.
19. de Sonneville LMJ, Njiokiktjien C, Bos H. 1994. Methylphenidate and information processing. Part 1: differentiation between responders and nonresponders; Part 2: efficacy in responders. J Clin Exp Neuropsychol 16: 877-897.
20. Douglas VI. 1999. Cognitive control processes in Attention-Deficit Hyperactivity Disorder. In Handbook of Disruptive Behaviour Disorders, Quay HC, Hogan AE (eds). Plenum Press: New York, 105-138.
21. Douglas VI, Barr RG, Desilets J, Sherman E. 1995. Do high doses of stimulants impair flexible thinking in Attention-Deficit Hyperactivity Disorder? J Am Acad Child Adolesc Psychiatry 34 877-885.
22. Douglas VI, Barr RG, O'Neill ME, Britton BG. 1986. Short term effects of methylphenidate on the cognitive learning and academic performance of children with Attention Deficit Disorder in the laboratory and the classroom. J Child Psychol Psychiatr 27: 191-211.
23. DuPaul G, Barkley RA, McMurray MB. 1994. Response of children with ADHD to methylphenidate: interaction with internalizing symptoms. J Am Acad Child Adolesc Psychiatry 33: 894-903.
24. Efron D, Jarman F, Barker M. 1997. Methylphenidate versus dexamphetamine in children with Attention Deficit Hyperactivity Disorder: a double-blind crossover trial. Pediatrics 100: E6.
25. Elia J, Borcherding BG, Rapoport JL, Keysor CS. 1991. Methylphenidate and dextroamphetamine treatments of hyperactivity: are there true nonresponders? Psychiatry Res 36: 141-155.
26. Gray JR, Kagan J. 2000. The challenge of predicting which children with Attention Deficit-Hyperactivity Disorder will respond positively to methylphenidate. J Appl Dev Psychol 21: 471-489.
27. Greenberg LM, Waldman ID. 1993. Developmental normative data on the test of variables of attention (T.O.V.A.). J Child Psychol Psychiatry 34: 1019-1030.
28. Greenhill LL. 2001. Clinical effects of stimulant medication in ADHD. In Stimulant Drugs and ADHD, Solanto MN, Arnsten AFT, Castellanos FX (eds). Oxford University Press: New York, 31-71.
29. Hoagwood K, Kelleher KJ, Feil MMS, Comer DM. 2000. Treatment services for children with ADHD: a national perspective. J Am Acad Child Adolesc Psychiatry 39: 198-206.
30. Ingraham LJ, Aitken CB. 1996. An empirical approach to determining criteria for abnormality in test batteries with multiple measures. Neuropsychology 10: 120-124.
31. Jacobson NS, Traux P. 1991. Clinical significance: a statistical approach to defining meaningful change in psychotherapy research. J Consult Clin Psychol 59: 12-19.
32. Kent MA, Camfield CS, Camfield PR. 1999. Double-blind methylphenidate trials: practical useful and highly endorsed by families. Arch Pediatr Adolesc Med 153: 1292-1296.
33. Maruff P, Currie J, Pantelis C, Smith D. 1996. Deficits in the endogenous control of covert attention in chronic schizophrenia. Neuropsychologia 34: 1079-1084.
34. McCaffrey RJ, Westervelt HJ. 1995. Issues associated with repeated neuropsychological assessments. Neuropsychol Rev 5: 203-221.
35. Mollica CM, Maruff P, Collie A, Vance A. 2004a. The effects of age and practice on the stability of performance on a computerized assessment of cognitive change in children. Child Neuropsychol in press.
36. Mollica CM, Maruff P, Vance A, Collie A. 2004b. The effects of stimulant medication on the cognitive and behavioural function of children with attention-deficit/hyperactivity disorder-combined type (ADHD-CT). J Clin Psychiatry submitted.
37. Nigg JT, Blaskey LG, Huang-Pollock CL, Rappley MD. 2002. Neuropsychological executive functions and DSM-IV ADHD subtypes. J Am Acad Child Adolesc Psychiatry 41: 59-66.
38. Paule MG, Rowland AS, Ferguson SA, et al. 2000. Attention Deficit/Hyperactivity Disorder: characteristics interventions and models. Neurotoxicol Teratol 22: 631-351.
39. Rapport MD, Denney CB. 2000. Attention Deficit Hyperactivity Disorder and methylphenidate: assessment and prediction of clinical response. In Ritalin: Theory and Practice, Greenhill LL, Osman BB (eds). Mary Ann Liebert: Larchmont NY, 45-70.
40. Rapport MD, Kelly KL. 1993. Psychostimulant effects on learning and cognitive function. In Handbook of Hyperactivity in Children, Matson JL (ed.). Allyn & Bacon: Boston, 97-136.
41. Rasmussen LS, Larsen K, Houx P, Skovgaard LT, Hanning CD, Moller JT. 2001. The assessment of postoperative cognitive function. Acta Anaesthesiol Scand 45: 275-289.
42. Rodgers J, Marckus R, Kearns P, Windebank K. 2003. Attentional ability among survivors of leukaemia treated without cranial irradiation. Arch Dis Child 88: 147-150.
43. Rutter M, Graham P. 1968. The reliability and validity of the psychiatric assessment of the child: I. Interview with the child. Br J Psychiatry 114: 563-579.
44. Silbert BS, Maruff P, Evered LA, et al. 2004. Detection of cognitive decline after coronary surgery: a comparison of computerised and conventional tests. Br J Anaesth 92: 814-820.
45. Sprague RL, Sleator EK. 1977. Methylphenidate in hyperkinetic children: differences in dose effects on learning and social behaviour. Science 198: 1274-1276.
46. Swanson JM, Kinsbourne M, Roberts W, Zucker K. 1978. Time-response analysis of stimulant medication on the learning ability of children referred for hyperactivity. Pediatrics 61: 21-29.
47. Swanson JM, McBurnett K, Wigal T, Pfiffner LJ, Williams L, Christian DL. 1993. Effects of stimulant medication on children with attention deficit disorder: a 'review of reviews'. Exceptional Children 60: 154-162.
48. Tannock R, Ickowicz A, Schachar R. 1995. Differential effects of methylphenidate on working memory in ADHD children with and without comorbid anxiety. J Am Acad Child Adolesc Psychiatry 34: 886-896.
49. Taylor E, Schachar R, Thorley G, Wieselberg HM, Everitt B, Rutter M. 1987. Which boys respond to stimulant medication? A controlled trial of methylphenidate in boys with disruptive behaviour. Psychol Med 17: 121-143.
50. Vance A, Barnett R (eds). 2002. Children's Impulsiveness Scale. Alfred Hospital: Melbourne Australia.
51. Winer BJ (ed.). 1971. Statistical Principles in Experimental Design. McGraw-Hill: London.
52. Wood K, Maruff P, Farrow M, Levy F, Hay D. 1999. Covert orienting of visual attention in children with attention deficit disorder: does comorbidity make a difference? Arch Neuropsychol 14: 179-189.